# Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock

> **NCT00604019** · PHASE3 · COMPLETED · sponsor: **Rush University Medical Center** · enrollment: 252 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Dopamine
- **DRUG:** Norepinephrine

## Key facts

- **NCT ID:** NCT00604019
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 252 (ACTUAL)
- **Last updated:** 2023-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00604019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00604019, "Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00604019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*